Xcout IntelSign inSubscribe

Intercure Ltd.

INCRPharmaceuticalsHerzliya, Israel

InterCure Ltd., including its subsidiaries, is actively involved in the entire lifecycle of medical cannabis products. This encompasses everything from initial research and cultivation to manufacturing, marketing, and global distribution, serving both the Israeli market and international territories. The company's offerings feature dried cannabis flower alongside cannabis extracts infused with oil. Beyond its core cannabis operations, InterCure also directs investments towards the biomedical sector. Founded in 1994, the firm's main offices are located in Herzliya, Israel.

Subscribe to see Intercure Ltd.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

Intercure Ltd. at a glance

Intercure Ltd. is a pharmaceuticals company headquartered in Herzliya, Israel, founded in 1994. It is publicly listed (INCR) with a market capitalisation of $77M. Xcout tracks 23 named people at Intercure Ltd., including Einat Zehavi (Chief Executive Officer of Retail).

Industry
Pharmaceuticals
Headquarters
Herzliya, Israel
Market cap
$77M
Employees
320
Ticker
INCR
Founded
1994

Intercure Ltd. leadership

  • Einat ZehaviChief Executive Officer of Retail
  • Amos CohenChief Financial Officer
  • Omer LayaniChief Technology Officer
  • Alexander RabinovichFounder, CEO & Chairman
  • Prof. Dedi MeiriChairperson, Scientific Advisory Board
  • Dor HershkowitzVP, Global Business Development

17 more named people on record for Intercure Ltd., with roles, board committees and tenure — see the full roster →

Intercure Ltd. funding rounds before its IPO

Every round on record:

DateRoundAmountInvestors
—$12M2 named

Financing after the IPO — public offerings and SEC Form D private placements — is not listed as a funding round.

Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →

Investors

Intercure Ltd. competitors

A few of Intercure Ltd.'s closest competitors — see the full list of competitors and alternatives →

TEVATEVA · PharmaceuticalsTel Aviv, Israel
63% matchPublic

Teva Pharmaceutical Industries Limited functions as a global pharmaceutical enterprise, involved in the conception, manufacturing, marketing, and provision of a broad spectrum of generic, specialty, and biopharmaceutical products throughout North America, Europe, and various international markets. The company's diverse product range includes sterile items, hormones, potent drugs, and cytotoxic agents, available in numerous forms like tablets, capsules, injectable solutions, inhalable preparations, liquids, transdermal patches, topical ointments, and creams. Additionally, Teva develops, produces, and sells active pharmaceutical ingredients (APIs). The firm prioritizes several key therapeutic domains: central nervous system disorders, pain management, respiratory ailments, and oncology. In the central nervous system sector, prominent products include Copaxone, intended for relapsing forms of multiple sclerosis; AJOVY, prescribed for preventing migraines; and AUSTEDO, which targets tardive dyskinesia and chorea linked to Huntington's disease. For respiratory conditions, Teva offers medications such as ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick, all designed to treat asthma and chronic obstructive pulmonary disease. The oncology portfolio features therapies like Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited is also engaged in a collaboration with MedinCell to advance and commercialize multiple long-acting injectable formulations, notably a risperidone suspension for individuals affected by schizophrenia. The company was established in 1901 and its primary headquarters are located in Tel Aviv-Yafo, Israel.

Market cap$45.8B
Employees37,000
TEVA competitors & alternatives →

Get Intercure Ltd.'s news by email

Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.

Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →

Share this card

Post the link and the card appears automatically — each network fetches the image itself.

Intercure Ltd. — share card preview

Instagram, TikTok and Slack canvases don't expand links — download the card as a PNG and post it as an image instead.

More on Intercure Ltd. in Xcout Intel

  • 23 named people with titles, LinkedIn and board committees
  • 1 funding round before the IPO with the investors in each, and who they co-invest with
  • The full competitor set, tracking, exports and API access
Subscribe to Xcout Intel →